Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Delmar Pharmaceuticals Inc (DMPI)

Delmar Pharmaceuticals Inc (DMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,318
  • Shares Outstanding, K 11,454
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,050 K
  • 60-Month Beta 1.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade DMPI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 09/08/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +89.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8522 +57.24%
on 07/27/20
1.5300 -12.42%
on 08/11/20
+0.4600 (+52.27%)
since 07/17/20
3-Month
0.6100 +119.67%
on 07/02/20
1.5300 -12.42%
on 08/11/20
+0.6390 (+91.16%)
since 05/19/20
52-Week
0.3800 +252.63%
on 03/26/20
1.5300 -12.42%
on 08/11/20
+0.5650 (+72.90%)
since 08/19/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DelMar Pharmaceuticals, Inc. is involved in developing drug for orphan cancer indications. DelMar Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.4667
1st Resistance Point 1.4033
Last Price 1.3400
1st Support Level 1.2233
2nd Support Level 1.1067
3rd Support Level N/A

See More

52-Week High 1.5300
Last Price 1.3400
Fibonacci 61.8% 1.0907
Fibonacci 50% 0.9550
Fibonacci 38.2% 0.8193
52-Week Low 0.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar